Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01988935 · ClinicalTrials.gov registry record · NA

Integrated PTSD and Smoking Treatment

A NA study, sponsored by University of Texas at Austin.

Completed
Registry status
NA
Development phase
70
Enrollment target

NCT01988935 is a NA study that has completed, run by University of Texas at Austin. The registered enrollment target is 70 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01988935, a NA study, has completed, sponsored by University of Texas at Austin.

COMPLETED
Registry status
NA
Development phase
70 participants
Enrollment target

Study Summary

Research shows that people with PTSD are more likely to smoke than people without PTSD. It also shows that people with PTSD have more difficulty at attempts to quit smoking. This study is part of a program aimed at finding out how best to help smokers quit who also have PTSD. One option is to give patients standard smoking cessation treatment including nicotine replacement and cognitive behavioral therapy. Another option is to give patients the standard smoking cessation treatment in addition to treatment for their PTSD symptoms (called prolonged exposure). However, it is not known which method works better. In order to answer this question, patients will be assigned by chance to one of two groups. One group will be given standard smoking cessation treatment to help quit smoking. A second group will be given the standard smoking cessation intervention to help quit smoking in addition to a form of psychotherapy called Prolonged Exposure to reduce symptoms of PTSD. The patients will be randomly assigned (by chance) to one of these groups. If the patient is assigned to the smoking cessation only condition and the patient still has PTSD symptoms after the last study visit (week 30) the patient will be offered treatment for your PTSD symptoms (Prolonged Exposure) at no cost. The patient's participation will help the investigators determine if treating PTSD symptoms enhances the ability of standard smoking cessation to help people quit smoking.

Interventions

  • BEHAVIORAL Smoking Cessation
  • BEHAVIORAL Prolonged Exposure

Trial Details

FieldValue
Enrollment Target 70 participants
Start Date 2013-10
Est. Completion 2020-06
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT01988935

The ClinicalTrials.gov registry entry for NCT01988935 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Smoking Cessation is the first listed.

NCT01988935 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01988935 about?

NCT01988935 is a clinical study titled "Integrated PTSD and Smoking Treatment". Research shows that people with PTSD are more likely to smoke than people without PTSD. It also shows that people with PTSD have more difficulty at attempts to quit smoking. This study is part of a program aimed at finding out how best to help smokers quit who also have PTSD. One option is to give p...

What is the current status of trial NCT01988935?

This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2013-10. Estimated completion is 2020-06.

What interventions are being tested in trial NCT01988935?

The interventions under investigation include: Smoking Cessation (BEHAVIORAL), Prolonged Exposure (BEHAVIORAL).

Who is sponsoring clinical trial NCT01988935?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.